Sector |
|
Compare with Sector peers |
Industry |
|
Compare with Industry peers |
Website | http://www.dolphinmedicalindia.com | |
Market Cap | 2.49 Cr. | |
Enterprise Value(EV) | 3.19 Cr. | 2022-09 |
Financial Indicators | ||
---|---|---|
Earnings per share (EPS) | -0.06 | Trailing Twelve Months Ending 2022-12 |
Price-Earning Ratio (PE) | - | Trailing Twelve Months Ending 2022-12 |
Industry PE | 45.84 | Trailing Twelve Months Ending 2022-12 |
Book Value / Share | 6.80 | Trailing Twelve Months Ending 2022-12 |
Price to Book Value | 0.24 | Calculated using Price: 1.65 |
Dividend Yield | 0.00 | Period Ending 2022-03 |
No. of Shares Subscribed | 1.51 Cr. | 15,099,952 Shares |
FaceValue | 10 | |
Company Profile | ||
Dolphin Medical Services Ltd. is an organization promoted by the doctors of the region. The chief promoters are Dr. M S S Koteswara Rao, an eminent physician and former Minister for health in Andhra Pradesh and Dr. G V Mohan Prasad, a radiologist cum ENT specialist who is also the Managing Director of the company. Dolphin was founded with a lofty ideal of providing quality medical services to improve the quality of life of the people through better health, in the last decade of the the 20th century by renowned medical technologists. |
1 Day |
|
|
1 Week |
|
|
1 Month |
|
-2.94% |
3 Month |
|
-4.62% |
6 Month |
|
-6.78% |
1 Year |
|
-21.05% |
2 Year |
|
+1.23% |
5 Year |
|
+38.66% |
10 Year |
|
+43.48% |
9 years | 2014-03 | 2015-03 | 2016-03 | 2017-03 | 2018-03 | 2019-03 | 2020-03 | 2021-03 | 2022-03 | |
Return on Equity (%) | -6.26 | -4.39 | -0.36 | -2.12 | -2.41 | -8.60 | -3.50 | -2.93 | -1.80 | |
Return on Capital Employed (%) | -3.68 | -2.56 | -0.06 | -1.43 | -1.57 | -5.38 | -2.07 | -2.01 | -1.50 | |
Return on Assets (%) | -3.80 | -2.62 | -0.21 | -1.25 | -1.41 | -5.15 | -2.15 | -2.07 | -1.53 |
Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2022-09* Rs. Cr. |
Shh. Funds | 13 | 13 | 13 | 12 | 12 | 11 | 11 | 10 | 10 | 10 | |
Non Curr. Liab. | 9 | 9 | 9 | 9 | 9 | 7 | 7 | 1 | 1 | 1 | |
Curr. Liab. | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | |
Minority Int. | |||||||||||
Equity & Liab. | 22 | 22 | 22 | 21 | 21 | 18 | 18 | 12 | 12 | 12 | |
Non Curr. Assets | 21 | 20 | 20 | 19 | 19 | 16 | 16 | 10 | 10 | 10 | |
Curr. Assets | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | |
Misc. Exp. not W/O | |||||||||||
Total Assets | 22 | 22 | 22 | 21 | 21 | 18 | 18 | 12 | 12 | 12 |
Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2022-12 Rs. Cr. TTM |
Net Sales | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | |
Other Income | 0 | 0 | 0 | 0 | 0 | 0 | 6 | 0 | 0 | ||
Total Income | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 6 | 1 | 1 | |
Total Expenditure | -1 | 0 | 0 | 0 | 0 | -1 | -1 | -6 | -1 | -1 | |
PBIDT | 0 | 0 | 0 | 0 | 0 | -1 | 0 | 0 | 0 | 0 | |
Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
Depreciation | -1 | -1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
Taxation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
Exceptional Items | |||||||||||
PAT | -1 | -1 | 0 | 0 | 0 | -1 | 0 | 0 | 0 | 0 | |
Adjusted EPS | -1 | 0 | 0 | 0 | 0 | -1 | 0 | 0 | 0 | 0 |
Particulars | 10 years | 2013-03 Rs. Cr. | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. |
Cash Fr. Operatn. | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
Cash Fr. Inv. | 0 | 0 | 0 | 0 | 2 | 0 | |||||
Cash Fr. Finan. | 0 | 0 | 0 | 0 | 0 | -2 | 0 | 0 | 0 | ||
Net Change | 0 | 0 | 0 | ||||||||
Cash & Cash Eqvt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Mon, 13 Feb 2023
Un Audited Financial Results For The Quarter Ended 31.12.2022 Un audited Financial Results for the Quarter ended 31.12.2022 |
Mon, 06 Feb 2023
Board Meeting Intimation for To Consider And Approve Unaudited Results For The Quater Ended 31.12.2022 DOLPHIN MEDICAL SERVICES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/02/2023 inter alia to consider and approve unaudited results for the quater ended 31.12.2022 |
Tue, 03 Jan 2023
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 Compliance Certificate under Reg.7(5) |
Mon, 20 Mar 2023 |
|
|
|